ERLONAT ERLOTINIB TABLETS IP

Get a Price/Quote

ERLONAT ERLOTINIB TABLETS IP Specification

Salt Composition
Erlotinib Hydrochloride

Indication
Non-small cell lung cancer, Pancreatic cancer

Dosage Form
Tablet

Enzyme Types
Tyrosine kinase inhibitor (TKI)

Feature
Film-coated, prescription only

Ingredients
Erlotinib Hydrochloride, Excipients

Application

Physical Color/Texture
White to off-white, round tablet

Fermentation Smell
Odorless

Enzymatic Activity
Blocks EGFR tyrosine kinase

Storage Instructions
Store below 30C, protected from moisture and light

Shelf Life
24 months from date of manufacture

ERLONAT ERLOTINIB TABLETS IP Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About ERLONAT ERLOTINIB TABLETS IP

Erlonat 150 Mg

Erlonat 150 Mg Tablets Erlotinib Generic

We Are The Wholesale Dealers Of Erlonat Tablets Which Is Available As 100 Mg & 150 Mg. We Exports These Medicines To The Usa, Uk, Hongkong, Singapore, Malaysia, China, & Thailand.

Specifications

Product Name - Erlonat 150 Mg Tablets
Content - Erlotinib Hydrochloride
Form - Tablets
Strength - 25 Mg, 100Mg, 150 Mg
Packing - Pack Of 30 Tablets
Manufactured By : Natco

Note :-ErlonatIs A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

Key Features of ERLONAT ERLOTINIB Tablets

ERLONAT ERLOTINIB is a prescription antineoplastic agent formulated as film-coated tablets for oral administration. Available in 100 mg and 150 mg strengths, each tablet contains Erlotinib Hydrochloride for targeted cancer therapy. Its main therapeutic benefit is the inhibition of EGFR tyrosine kinase, making it effective against certain types of lung and pancreatic cancer. Tablets are odorless, round, and white to off-white in color.

Indications and Therapeutic Benefits

ERLONAT is specifically indicated for non-small cell lung cancer and pancreatic cancer treatment. By blocking EGFR tyrosine kinase activity, it helps slow down cancer progression. The tablets can be used as part of chemotherapy regimens under the supervision of an oncologist, offering targeted action for oncology patients.

How to Store and Handle ERLONAT

The tablets must be stored below 30C and protected from moisture and light to maintain efficacy throughout their 24-month shelf life. Its essential to follow proper storage recommendations and only use the medication as directed by a qualified medical professional.

FAQs of ERLONAT ERLOTINIB TABLETS IP:

Q: How should ERLONAT ERLOTINIB Tablets be taken for best results?

A: ERLONAT tablets are intended for oral use and should be taken exactly as prescribed by your oncologist, typically on an empty stomach or as directed. Do not adjust your dose or frequency without consulting your doctor.

Q: What conditions are ERLONAT ERLOTINIB Tablets indicated for?

A: These tablets are used mainly to treat non-small cell lung cancer and pancreatic cancer. Your oncologist will determine whether ERLONAT is suitable for your case based on your diagnosis.

Q: When is the most appropriate time to start ERLONAT therapy?

A: Treatment with ERLONAT should begin only after a thorough assessment and prescription by an oncologist, typically as part of a comprehensive cancer treatment plan.

Q: Where should I store ERLONAT ERLOTINIB Tablets to ensure their effectiveness?

A: Store the tablets below 30C, in a dry place, protected from moisture and light. Keeping them in the original packaging helps preserve their quality throughout the shelf life.

Q: What is the process for obtaining ERLONAT ERLOTINIB Tablets?

A: ERLONAT is a prescription-only medication. It must be obtained through a licensed pharmacy after a qualified oncologists evaluation and prescription.

Q: What are the benefits of using ERLONAT in cancer treatment?

A: ERLONAT acts as a tyrosine kinase inhibitor, blocking EGFR-dependent pathways to slow cancer cell growth. It offers targeted therapeutic effects, particularly effective in non-small cell lung and pancreatic cancers when used as prescribed.

Tell us about your requirement